The increased cytolytic activity of Hsp70-activated NK cells can be blocked either by a CD94 specific blocking antibody for NK cells or by an Hsp70 specific antibody for blocking mHsp70 on tumor cells (Krause et al., 2004). Here, KLRD1 is linked to neoplasm.